Regulation of EBV reactivation
Regulation of EBV reactivation
批准号:
7380221
负责人:
PAUL M LIEBERMAN
金额:
$25.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-27 至 2012-07-31
关键词:
AffinityB-LymphocytesBZLF1 protein, Herpesvirus 4, HumanBindingBinding ProteinsBiochemicalBiochemistryBiological AssayBiologyCCAAT-Enhancer-Binding ProteinsCamptothecinCell modelChemicalsCysteineDNADNA BindingDNA biosynthesisDNA-Binding ProteinsDataElementsEnvironmentEpithelialEpithelial CellsEpitopesEpstein-Barr Virus InfectionsEpstein-Barr pathogenesisEthylmaleimideFamilyGenetic TranscriptionGenomeHerpesviridaeHistone AcetylationHistonesHumanHuman Herpesvirus 4Human Herpesvirus 8Human herpesvirus 8 K8 proteinImmediate-Early ProteinsIndiumInfectionInstitutesIntegration Host FactorsLinkLymphoidLyticLytic PhaseMalignant NeoplasmsModificationOncogenicOxidation-ReductionProcessPropertyProteinsProteomicsRecruitment ActivityRegulationSS DNA BPSimplexvirusSingle-Stranded DNASiteStructureTestingTimeTopoisomerase-I InhibitorViralVirus Diseasescell typegenome-wide analysishelicasein vivoinhibitor/antagonistlytic replicationmembernoveloxidationresearch studysmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Epstein-Barr virus (EBV) is an oncogenic human herpesvirus that has been linked to lymphoid and epithelial malignancies. The propagation and pathogenesis of EBV depends on the efficient activation of the viral lytic cycle. The primary initiator of the EBV lytic cycle is the immediate early protein Zta (also referred to as ZEBRA, BZLF1, and EB1). Zta is an atypical member of the basic-leuzine zipper (b-zip) family of DNA binding proteins with sequence similarity to the cellular C/EBP family, and functional homology with the Kaposi's Sarcoma Associated Herpesvirus (KSHV) K8 protein. Zta can bind to multiple sequence elements in the viral and cellular genome to stimulate transcription activity and origin-specific DNA replication. Zta can also pirate host factors necessary to create a permissive environment for viral replication. The ability of Zta to bind the viral origin of lytic cycle DNA replication (OriLyt) and nucleate a viral replisome suggests that is the EBV origin binding protein (OBP), and likely to share properties with the alpha and beta herpesvirus OBP UL9. New preliminary data indicates that Zta possesses single stranded DNA binding activity and can recognize a DNA hairpin that forms at the essential upstream element of OriLyt. Zta, like UL9, have a highly conserved and redox sensitive cysteine residue that is essential for replication function and single strand DNA binding. A redox sensitive cysteine is also essential for activation of C/EBP 2, a cellular factor that nucleates the KSHV lytic origin replisome. In this application, we propose to investigate the biochemistry, regulation, and genome biology of Zta in the reactivation of EBV lytic replication. We will test the overarching hypothesis that Zta shares biochemical and functional properties with other herpesvirus OBPs and that these common properties are essential for regulation and initiation of lytic replication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 4: Regulation of EBV Latency and Oncogenesis by Hypoxia
-
批准号:10714176
-
项目类别:
-
资助金额:$47.49万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Epigenomic Drivers of EBV Epithelial Cancers
-
批准号:10627690
-
项目类别:
-
资助金额:$46.97万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
-
批准号:10627689
-
项目类别:
-
资助金额:$243.61万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
-
批准号:10719866
-
项目类别:
-
资助金额:$74.58万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Administrative and Biostatistics
-
批准号:10627693
-
项目类别:
-
资助金额:$15.99万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Epigenetic Regulation of Epstein-Barr Virus
-
批准号:10363894
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2022
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Epigenetic Regulation of Epstein-Barr Virus
-
批准号:10550255
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2022
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Drugging EBNA1 to Treat EBV-Associated Cancers - Diversity Supplement
-
批准号:10818976
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Drugging EBNA1 to Treat EBV-Associated Cancers
-
批准号:10185459
-
项目类别:
-
资助金额:$58.25万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Regulation of EBV Latency by Purine Metabolism and Signaling
-
批准号:10298045
-
项目类别:
-
资助金额:$45.76万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Regulation of EBV Latency by Purine Metabolism and Signaling
-
批准号:10407656
-
项目类别:
-
资助金额:$45.76万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Development of a Small Molecule Inhibitor for KSHV LANA
-
批准号:8856529
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Development of a Small Molecule Inhibitor for KSHV LANA
-
批准号:8732352
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Development of a Small Molecule Inhibitor for KSHV LANA
-
批准号:9057999
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2014
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Chromatin Regulation of KSHV Primary Infection
-
批准号:8874167
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Chromatin Regulation of KSHV Primary Infection
-
批准号:8541139
-
项目类别:
-
资助金额:$40.17万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Purchase of a Biacore T200 Surface Plasmon Resonance Label-free Detection System
-
批准号:8447935
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
ChIP Sequencing Core
-
批准号:8874170
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
ChIP Sequencing Core
-
批准号:8541143
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Conference Support for International Congress on Oncogenic Herpesviruses
-
批准号:8400154
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2012
-
负责人:PAUL M LIEBERMAN
-
依托单位:
海外基金